Table 4.
Awareness, treatment, and control of HTN among people with a previous diagnosis of HTN, Isfahan, Iran, 2016
| Age (yr) | Awareness |
Pharmacological treatment |
HTN control |
|||
|---|---|---|---|---|---|---|
| Yes | No | Yes | No | Yes | No | |
| Total | 252 (69.2) | 112 (30.8) | 231 (92.4) | 19 (7.6) | 151 (59.9) | 101 (40.1) |
| 18-29 | 2 (7.7) | 24 (92.3) | 1 (50.0) | 1 (50.0) | 1 (50.0) | 1 (50.0) |
| 30-39 | 7 (38.9) | 11 (61.1) | 5 (71.4) | 2 (28.6) | 4 (57.1) | 3 (42.9) |
| 40-49 | 38 (67.9) | 18 (32.1) | 34 (89.5) | 4 (10.5) | 27 (71.1) | 11 (28.9) |
| 50-59 | 68 (74.7) | 23 (25.3) | 61 (91.0) | 6 (9.0) | 40 (58.8) | 28 (41.2) |
| 60-69 | 68 (77.3) | 20 (22.7) | 64 (94.1) | 4 (5.9) | 43 (63.2) | 25 (36.8) |
| ≥70 | 69 (81.2) | 16 (18.8) | 66 (97.1) | 2 (2.9) | 36 (52.2) | 33 (47.8) |
| p-value1 | <0.001 | 0.03 | 0.53 | |||
Values are presented as number (%).
HTN, hypertension.
1
p-values of the chi-square test.